These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8677644)

  • 21. Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2005 Dec; (14):1498-505. PubMed ID: 16620460
    [No Abstract]   [Full Text] [Related]  

  • 22. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J; Sibley JT; Haga M
    J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Individual prophylaxis against NSAID ulcers?].
    Bolten WW
    Fortschr Med; 1995 Apr; 113(10):1. PubMed ID: 7737616
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
    Bhatt CB; Pipalia DH; Naik SR; Tilve GH
    J Postgrad Med; 1988 Oct; 34(4):224-8. PubMed ID: 3151214
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-steroidal anti-inflammatory drugs.
    Gøtzsche P
    Clin Evid; 2002 Dec; (8):1203-11. PubMed ID: 12603936
    [No Abstract]   [Full Text] [Related]  

  • 26. Controversies, dilemmas, and dialogues. What do you recommend for prophylaxis in an elderly woman with arthritis requiring NSAIDs for control?
    Jones MP; Schubert ML; Smith JL
    Am J Gastroenterol; 1991 Mar; 86(3):264-8. PubMed ID: 1900141
    [No Abstract]   [Full Text] [Related]  

  • 27. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?
    Wu CS; Wang SH; Chen PC; Wu VC
    Int J Clin Pract; 1998 Oct; 52(7):472-4. PubMed ID: 10622088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of the gastric mucosa from NSAIDs.
    Fenn GC
    N Z Med J; 1992 Oct; 105(944):436. PubMed ID: 1297946
    [No Abstract]   [Full Text] [Related]  

  • 29. [Digestive and extra-digestive complications of nonsteroidal anti-inflammatory drugs. Preventive and curative strategies].
    Sternon J; Adler M
    Rev Med Brux; 1997 Apr; 18(2):52-8. PubMed ID: 9221462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis at what cost? The debate continues.
    Robinson AB; Clement DJ
    Am J Gastroenterol; 1994 Aug; 89(8):1264-6. PubMed ID: 8053452
    [No Abstract]   [Full Text] [Related]  

  • 31. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions: a commentary on the new data.
    Lanza FL
    Am J Med; 1998 Mar; 104(3A):75S-78S; discussion 79S-80S. PubMed ID: 9572325
    [No Abstract]   [Full Text] [Related]  

  • 33. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data.
    Talley NJ
    Am J Med; 1998 Mar; 104(3A):62S-66S; discussion 79S-80S. PubMed ID: 9572323
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prostaglandin analogues in ulcer disease].
    Malmquist J
    Ugeskr Laeger; 1989 Apr; 151(16):1005. PubMed ID: 2502876
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonsteroidal anti-inflammatory drug use in dentistry: gastrointestinal implications.
    Nguyen AM; Graham DY; Gage T; Griffiths GR
    Gen Dent; 1999; 47(6):590-6; quiz 597-8. PubMed ID: 10687453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2002 Jun; (7):1063-70. PubMed ID: 12230727
    [No Abstract]   [Full Text] [Related]  

  • 37. The development of clinical practice guidelines for treatment of peptic acid diseases in a VA ambulatory care clinic--a comment.
    Holt RJ; Fort J
    Pharmacotherapy; 1996; 16(3):480-1; discussion 482-3. PubMed ID: 8726612
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of gastroduodenal disorders due to non-steroidal anti-inflammatory drugs].
    Hameeteman W; Dekker W
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):723-4. PubMed ID: 2038401
    [No Abstract]   [Full Text] [Related]  

  • 39. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
    Hawkey CJ
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265
    [No Abstract]   [Full Text] [Related]  

  • 40. Misoprostol and ulcer prophylaxis.
    Shield MJ; Fenn CG
    Lancet; 1989 Jan; 1(8629):98-9. PubMed ID: 2562901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.